Results 151 to 160 of about 68,907 (308)

Book Review: The Fixed Eruption: A Possible Hazard of Modern Drug Therapy

, 1962

openalex   +1 more source

Fixed drug eruptions. [PDF]

BMJ, 1985
openaire   +3 more sources

Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client‐owned dogs: A multicentre, double‐masked, randomised, placebo‐controlled clinical trial

Veterinary Dermatology, EarlyView.
Background – Inhibition of the Janus kinase (JAK) pathway is a well‐established option for canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, a novel JAK inhibitor for the control of pruritus and skin lesions in client‐owned dogs with cAD.
Sophie Forster, Candace M. Trout, Simona Despa, Annette Boegel, Darren Berger, Stephen King   +5 more
wiley   +1 more source

A case series on fixed drug eruptions [PDF]

, 2014
A 60 year old male truck driver with a history of recurrent skin boils presented with painful lesions on the glans penis that started a few days prior. A week ago he was treated with co-trimoxazole for skin abscesses on the left leg.
Cascone, John, Newby, Maxwell, Regunath, Hariharan   +2 more
core  

Serum immunoglobulins in fixed drug eruption

, 1977
Athanasios Theodoridis, T Tsabaos, C. Sivenas, J. Capetanakis   +3 more
openalex   +2 more sources

First‐in‐human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors

Cancer, Volume 131, Issue 13, 1 July 2025.
Abstract Background Indoleamine 2,3‐dioxygenase 1 (IDO1) is a heme‐containing enzyme that degrades tryptophan (Trp) to kynurenine (Kyn), which suppresses effector T cells and reduces antitumor activity. KHK2455 is a long‐acting selective IDO1 inhibitor that blocks the heme component of the IDO holoenzyme.
Timothy A. Yap, Olivier Rixe, Capucine Baldini, Ursa Brown‐Glaberman, Sergey Efuni, David S. Hong, Christophe Massard, Jameel Muzaffar, Andreea Varga, Emrullah Yilmaz, Yuta Ikawa, Lisa H. Shiue, Yi Liu, Matthew W. Hruska, Henry Zhao, Akihiro Tokunaga, Solmaz Sahebjam   +16 more
wiley   +1 more source

Cefotaxime induced generalized bullous fixed drug eruption - A case report

Toxicology Reports, 2018
Fixed drug eruption (FDE) is the most common cutaneous adverse drug reaction. Cefotaxime, a broad-spectrum third-generation cephalosporin, appeared to be a safe and effective therapy in greater than 90% of infections including cellulitis, abscesses and ...
R. Manikandan, A. Porselvi, G.C. Keerthana, K. Vaishnavi, S. Girija, Murali Narasimhan, TM. Vijayakumar   +6 more
doaj  

Developmental Disturbances in Animal Models of Autism Spectrum Disorder

Developmental Neurobiology, Volume 85, Issue 3, July 2025.
ABSTRACT Although the early signs of autism spectrum disorder (ASD) are widely studied, the significant ambiguity and heterogeneity in symptoms require the comparison of available models, approaches, and the search for common denominators and key indicators.
Kristof Laszlo, Zuzana Bacova, Dora Zelena, Jan Bakos   +3 more
wiley   +1 more source

Toxicodermias por beta-bloqueantes [PDF]

, 2019
La hipertensión arterial es una enfermedad crónica que disminuye la calidad y expectativa de vida, ya que se agrava la morbimortalidad cardiovascular y renal.
Pradillo Heras, Cristina
core  

Fixed drug eruption due to minocycline—report of one case

, 1983
Marvin I. Lepaw
openalex   +1 more source